No date has been set, but TomoTherapy’s initial public offering of stock could be drawing near.
The Madison-based tech company on Thursday filed an amended registration statement with the U.S. Securities and Exchange Commission indicating that it could raise up to $213 million in its IPO. The company has applied to be listed on the Nasdaq Global Market under the symbol “TTPY.”
TomoTherapy says its “Hi-Art” cancer treatment system precisely delivers radiation with sub-millimeter accuracy to kill cancer cells while reducing radiation exposure to surrounding healthy tissue.